angiotensin ii has been researched along with rivaroxaban in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ako, J; Hashikata, T; Kameda, R; Kitasato, L; Murakami, M; Namba, S; Niwano, H; Shimohama, T; Tojo, T; Yamaoka-Tojo, M | 1 |
| Chen, H; Hu, R; Liu, C; Shao, J; Xie, P; Yang, D | 1 |
| Ichikawa, H; Kimura, Y; Narita, I; Narita, M; Okumura, K; Osanai, T; Shimada, M; Tanaka, M; Tomita, H | 1 |
| Chen, J; Guo, Y; Ji, T; Rao, Y; Xie, P | 1 |
| Cai, L; Ding, Y; Fu, W; Li, X; Shi, Z; Tang, H; Xie, T; Zhou, M | 1 |
| Fukuda, D; Hara, T; Ise, T; Kusunose, K; Matsuura, T; Sata, M; Soeki, T; Tobiume, T; Uematsu, E; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
| Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C | 1 |
7 other study(ies) available for angiotensin ii and rivaroxaban
| Article | Year |
|---|---|
Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB Pathway.
Topics: Angiotensin II; Animals; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Factor Xa Inhibitors; Fibroblasts; Fibrosis; Mice; Myocardium; NF-kappa B; Receptor, PAR-2; Rivaroxaban; Signal Transduction | 2015 |
Angiotensin II promotes the anticoagulant effects of rivaroxaban via angiotensin type 2 receptor signaling in mice.
Topics: Angiotensin II; Animals; Cells, Cultured; Cytokines; Diabetes Mellitus, Type 2; Disease Models, Animal; Factor Xa Inhibitors; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Mice, Inbred C57BL; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Rivaroxaban; Signal Transduction | 2017 |
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Topics: Albuminuria; Angiotensin II; Animals; Blood Coagulation; Factor Xa Inhibitors; Gene Knockdown Techniques; Glomerular Basement Membrane; Glomerular Mesangium; Humans; Hypertension; In Vitro Techniques; Inflammation; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Podocytes; Receptor, PAR-2; Renal Insufficiency, Chronic; Renin; Reverse Transcriptase Polymerase Chain Reaction; Rivaroxaban; Vasoconstrictor Agents | 2019 |
Rivaroxaban ameliorates angiotensin II-induced cardiac remodeling by attenuating TXNIP/Trx2 interaction in KKAy mice.
Topics: Angiotensin II; Animals; Carrier Proteins; Disease Models, Animal; Mice; Mice, Knockout; Rivaroxaban; Thioredoxins; Ventricular Remodeling | 2020 |
Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aortitis; Calcium Chloride; Cell Adhesion Molecules; Cytokines; Dilatation, Pathologic; Disease Models, Animal; Disease Progression; Factor Xa Inhibitors; Humans; Inflammation Mediators; Male; Mice, Knockout, ApoE; Retrospective Studies; Rivaroxaban; Signal Transduction; Vascular Remodeling | 2021 |
Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Factor Xa; Inflammation; Mice; Rats; Receptor, PAR-2; Rivaroxaban; Signal Transduction; Warfarin | 2021 |
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy | 2017 |